A study from the Norwegian University of Science and Technology (NTNU) found that Janus kinase (JAK) inhibitors — a class of anti-inflammatory drugs — can suppress a key part of the immune response, potentially allowing viruses like influenza and COVID-19 to replicate and spread more easily.

<p>A study from the Norwegian University of Science and Technology (NTNU) found that Janus kinase (JAK) inhibitors &mdash; a class of anti-inflammatory drugs &mdash; can suppress a key part of the immune response, potentially allowing viruses like influenza and COVID-19 to replicate and spread more easily.</p>